Dagmar Hönack

3.6k total citations
48 papers, 3.1k citations indexed

About

Dagmar Hönack is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Dagmar Hönack has authored 48 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cellular and Molecular Neuroscience, 29 papers in Psychiatry and Mental health and 21 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Dagmar Hönack's work include Neuroscience and Neuropharmacology Research (39 papers), Epilepsy research and treatment (29 papers) and Pharmacological Effects and Toxicity Studies (21 papers). Dagmar Hönack is often cited by papers focused on Neuroscience and Neuropharmacology Research (39 papers), Epilepsy research and treatment (29 papers) and Pharmacological Effects and Toxicity Studies (21 papers). Dagmar Hönack collaborates with scholars based in Germany, United States and Poland. Dagmar Hönack's co-authors include Wolfgang Löscher, Chris Rundfeldt, Wolfgang Löscher, W Löscher, Björn Nolting, C. P. Fassbender, J. Edward Fisher, Wolfgang Löscher, Piotr Właź and Ulrich Wahnschaffe and has published in prestigious journals such as Brain Research, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dagmar Hönack

48 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dagmar Hönack Germany 30 2.3k 1.5k 1.0k 954 273 48 3.1k
Zdzisław Kleinrok Poland 24 1.6k 0.7× 1.1k 0.7× 746 0.7× 438 0.5× 242 0.9× 63 2.2k
Wolfgang Löscher Germany 23 1.4k 0.6× 937 0.6× 563 0.6× 566 0.6× 168 0.6× 32 2.3k
Markus Schmutz Switzerland 26 1.8k 0.8× 745 0.5× 1.1k 1.1× 430 0.5× 358 1.3× 53 2.7k
L. Turski Poland 29 2.4k 1.0× 963 0.6× 1.0k 1.0× 441 0.5× 503 1.8× 57 3.1k
Kinga K. Borowicz Poland 26 1.2k 0.5× 1.1k 0.7× 615 0.6× 641 0.7× 116 0.4× 108 2.1k
Pavel Mareš Czechia 25 1.9k 0.8× 1.2k 0.7× 765 0.8× 549 0.6× 422 1.5× 213 2.6k
Luísa Rocha Mexico 26 1.5k 0.7× 712 0.5× 643 0.6× 348 0.4× 500 1.8× 147 2.5k
W Löscher Germany 25 1.1k 0.5× 945 0.6× 516 0.5× 773 0.8× 155 0.6× 43 1.9k
Nathalie Lambeng France 15 1.2k 0.5× 783 0.5× 845 0.8× 526 0.6× 100 0.4× 24 2.7k
Maciej Gąsior United States 35 1.7k 0.7× 893 0.6× 1.2k 1.1× 331 0.3× 276 1.0× 100 3.3k

Countries citing papers authored by Dagmar Hönack

Since Specialization
Citations

This map shows the geographic impact of Dagmar Hönack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Hönack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Hönack more than expected).

Fields of papers citing papers by Dagmar Hönack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Hönack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Hönack. The network helps show where Dagmar Hönack may publish in the future.

Co-authorship network of co-authors of Dagmar Hönack

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Hönack. A scholar is included among the top collaborators of Dagmar Hönack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Hönack. Dagmar Hönack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Löscher, Wolfgang, et al.. (1999). Effect of depth electrode implantation with or without subsequent kindling on GABA turnover in various rat brain regions. Epilepsy Research. 37(2). 95–108. 18 indexed citations
2.
Hönack, Dagmar, et al.. (1997). Intravenous Carbamazepine: Comparison of Different Parenteral Formulations in a Mouse Model of Convulsive Status Epilepticus. Epilepsia. 38(1). 106–113. 25 indexed citations
3.
Löscher, Wolfgang, Chris Rundfeldt, Dagmar Hönack, & Ulrich Ebert. (1996). Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 561–572. 30 indexed citations
4.
Baran, Halina, et al.. (1995). Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats. European Journal of Pharmacology. 286(2). 167–175. 34 indexed citations
5.
Löscher, Wolfgang & Dagmar Hönack. (1995). Anticonvulsant and antiepileptogenic effect of L-deprenyl (selegiline) in the kindling model of epilepsy.. Journal of Pharmacology and Experimental Therapeutics. 274(1). 307–314. 23 indexed citations
6.
Rundfeldt, Chris, Piotr Właź, Dagmar Hönack, & W Löscher. (1995). Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.. Journal of Pharmacology and Experimental Therapeutics. 275(2). 693–702. 47 indexed citations
7.
Löscher, Wolfgang, Ulrich Wahnschaffe, Dagmar Hönack, & Chris Rundfeldt. (1995). Does prolonged implantation of depth electrodes predispose the brain to kindling?. Brain Research. 697(1-2). 197–204. 55 indexed citations
8.
Löscher, Wolfgang, Piotr Właź, Chris Rundfeldt, Halina Baran, & Dagmar Hönack. (1994). Anticonvulsant effects of the glycine/NMDA receptor ligands d‐cycloserine and d‐serine but not R‐(+)‐HA‐966 in amygdala‐kindled rats. British Journal of Pharmacology. 112(1). 97–106. 56 indexed citations
9.
Löscher, Wolfgang & Dagmar Hönack. (1993). Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats. European Journal of Pharmacology. 234(2-3). 237–245. 22 indexed citations
10.
Löscher, Wolfgang, Heinz Nau, Ulrich Wahnschaffe, et al.. (1993). Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication. Epilepsy Research. 15(2). 113–131. 25 indexed citations
11.
Löscher, Wolfgang, Chris Rundfeldt, & Dagmar Hönack. (1993). Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Research. 15(3). 207–219. 83 indexed citations
12.
Hönack, Dagmar, et al.. (1993). Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. European Journal of Pharmacology. 242(3). 263–274. 77 indexed citations
13.
Löscher, Wolfgang & Dagmar Hönack. (1993). Effects of the novel 5-HT1A receptor antagonist, (+)-way 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats. European Journal of Pharmacology. 242(1). 99–104. 33 indexed citations
14.
Löscher, Wolfgang & Dagmar Hönack. (1993). Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. European Journal of Pharmacology. 232(2-3). 147–158. 228 indexed citations
15.
Löscher, Wolfgang, Ulrich Wahnschaffe, Dagmar Hönack, W. Wittfoht, & Heinz Nau. (1992). Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies. Epilepsy Research. 13(3). 187–198. 20 indexed citations
16.
Hönack, Dagmar & Wolfgang Löscher. (1992). Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin. Epilepsy Research. 13(3). 215–221. 37 indexed citations
17.
Löscher, Wolfgang, et al.. (1991). The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neuroscience Letters. 128(2). 191–194. 143 indexed citations
18.
Hönack, Dagmar, et al.. (1989). Physical dependence on diazepam in the dog: precipitation of different abstinence syndromes by the benzodiazepine receptor antagonists Ro 15–1788 and ZK 93426. British Journal of Pharmacology. 97(3). 843–852. 15 indexed citations
19.
Löscher, W, J. Edward Fisher, H. Nau, & Dagmar Hönack. (1989). Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.. Journal of Pharmacology and Experimental Therapeutics. 250(3). 1067–1078. 58 indexed citations
20.
Löscher, Wolfgang & Dagmar Hönack. (1989). Comparison of the anticonvulsant efficacy of primidone and phenobarbital during chronic treatment of amygdala-kindled rats. European Journal of Pharmacology. 162(2). 309–322. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026